Insider Transactions in Q4 2024 at Avadel Pharmaceuticals PLC (AVDL)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 24
2024
|
Linda Palczuk Director |
SELL
Bona fide gift
|
Direct |
3,500
-5.27%
|
-
|
|
Dec 13
2024
|
Thomas S Mchugh Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
2,300
+2.55%
|
$23,000
$10.44 P/Share
|
|
Dec 11
2024
|
Thomas S Mchugh Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+5.52%
|
$50,000
$10.49 P/Share
|
|
Dec 10
2024
|
Geoffrey Michael Glass Director |
BUY
Open market or private purchase
|
Indirect |
20,279
+12.29%
|
$182,511
$9.85 P/Share
|
|
Dec 09
2024
|
Gregory J Divis Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
402
+3.86%
|
$3,618
$9.82 P/Share
|
|
Dec 06
2024
|
Gregory J Divis Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
9,598
+50.0%
|
$86,382
$9.98 P/Share
|
|
Dec 06
2024
|
Linda Palczuk Director |
BUY
Open market or private purchase
|
Direct |
3,000
+4.32%
|
$30,000
$10.19 P/Share
|